Active Funding Opportunities and Notices for NICHD
NICHD publishes and participates in various notices of funding opportunities (NOFOs) and NIH Guide Notices (NOTs) to support research and training activities.
NOTs and Active NOFOs for NICHD
Please note: the following are sorted by date, from most recent to older. Select a table heading to change how to sort the information.
| Number | Exp. Date Sort ascending | Activity Code(s) | Title |
|---|---|---|---|
| NOT-MH-21-330 | September 8, 2024 | R01,UG3/UH3 | Notice of Special Interest (NOSI): Social, Behavioral, and Economic Impact of COVID-19 in Underserved and Vulnerable Populations |
| NOT-HD-23-001 | September 8, 2024 | R01,R15,R21,K01,R03 | Notice of Special Interest (NOSI): Mortality of Adolescents, Young Adults, and Other NICHD Priority Populations in the United States |
| NOT-HD-23-003 | September 8, 2024 | R21,R03,R01 | Notice of Special Interest (NOSI): Research to Improve Pre-Pregnancy Care and Enhance Healthy Birth Intervals |
| RFA-OD-24-012 | September 7, 2024 | T32 | Predoctoral Training in Advanced Data Analytics for Behavioral and Social Sciences Research (BSSR) - Institutional Research Training Program [T32] |
| PAR-24-202 | August 31, 2024 | SI2/R00 | Lasker Clinical Research Scholars Program (Si2/R00 Clinical Trial Optional) |
| NOT-EB-23-010 | August 31, 2024 | 333 | Notice of Special Interest (NOSI): Availability of Administrative Supplements for BRAIN Initiative Recipients to Support Resource Dissemination |
| RFA-MH-25-185 | August 14, 2024 | R01 | Advancing HIV service delivery through pharmacies and pharmacists (R01 Clinical Trial Optional) |
| RFA-MH-25-186 | August 14, 2024 | R21 | Advancing HIV service delivery through pharmacies and pharmacists (R21 Clinical Trial Optional) |
| PAR-24-206 | August 14, 2024 | U54 | Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Diseases Clinical Research Network (RDCRN) (U54 Clinical Trial Optional) |
| RFA-HD-25-001 | July 31, 2024 | P50 | Medical Rehabilitation Research Resource (P50 Clinical Trial Optional) |
| RFA-HD-25-004 | July 31, 2024 | U19 | Optimizing Health of Children and Adolescents with Perinatal HIV Exposure (U19 Clinical Trial Optional) |
| RFA-AI-24-018 | July 31, 2024 | R01 | Interaction between ARVs and Hormones in HIV and Coinfections (R01 Clinical Trial Optional) |
| RFA-HD-25-009 | July 25, 2024 | R21 | Using Archived Data and Specimen Collections to Advance Maternal and Pediatric HIV/AIDS Research (R21 - Clinical Trial Not Allowed) |
| NOT-NS-22-003 | July 17, 2024 | R01,R21 | Notice of Special Interest: Advancing Research in Gastrointestinal Dysfunction in People with Neurodevelopmental Disorders |
| NOT-OD-24-026 | July 16, 2024 | R21 | Notice of Special Interest (NOSI): Advance Data Science Approaches Through Secondary Data Analysis to Reveal Scientific Insights of COVID-19 Testing Technologies (R21) |
| RFA-AR-25-002 | July 4, 2024 | P50 | Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Centers (MDSRC) (P50 Clinical Trial Optional) |
| RFA-OD-21-007 | July 4, 2024 | R21 | INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Exploratory/Developmental Research Grant Award (R21 Clinical Trial Not Allowed) |
| RFA-AG-25-002 | July 3, 2024 | U54 | Consortium for Palliative Care Research Across the Lifespan (U54 Clinical Trial Optional) |
| RFA-OD-22-007 | July 2, 2024 | R21 | INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Clinical Trial Readiness (R21 Clinical Trial Not Allowed) |
| RFA-OD-22-009 | July 2, 2024 | R01 | Transformative Research Award for the INCLUDE (Investigation of Co-occurring Conditions across the Lifespan to Understand Down syndrome) Project (R01 Clinical Trial Not Allowed) |
BACK TO TOP